Perez-Lloret S

References (9)

Title : MicroRNAs and rs1803274 SNP-based BuChe downregulation are associated with metabolic syndrome through ghrelin hydrolysis and expression quantitative trait loci regulation in PD patients - Chevalier_2025_Front.Mol.Neurosci_18_1635201
Author(s) : Chevalier G , Udovin L , Otero-Losada M , Bordet S , Perez-Lloret S , Capani F
Ref : Front Mol Neurosci , 18 :1635201 , 2025
Abstract :
PubMedSearch : Chevalier_2025_Front.Mol.Neurosci_18_1635201
PubMedID: 41293127

Title : MicroRNAs and rs1803274 SNP-based BuChe downregulation are associated with metabolic syndrome through ghrelin hydrolysis and expression quantitative trait loci regulation in PD patients - Chevalier_2025_Front.Mol.Neurosci_18_1635201
Author(s) : Chevalier G , Udovin L , Otero-Losada M , Bordet S , Perez-Lloret S , Capani F
Ref : Front Mol Neurosci , 18 :1635201 , 2025
Abstract :
PubMedSearch : Chevalier_2025_Front.Mol.Neurosci_18_1635201
PubMedID: 41293127

Title : MicroRNAs and rs1803274 SNP-based BuChe downregulation are associated with metabolic syndrome through ghrelin hydrolysis and expression quantitative trait loci regulation in PD patients - Chevalier_2025_Front.Mol.Neurosci_18_1635201
Author(s) : Chevalier G , Udovin L , Otero-Losada M , Bordet S , Perez-Lloret S , Capani F
Ref : Front Mol Neurosci , 18 :1635201 , 2025
Abstract :
PubMedSearch : Chevalier_2025_Front.Mol.Neurosci_18_1635201
PubMedID: 41293127

Title : Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration - Perez-Lloret_2016_Expert.Opin.Pharmacother__1
Author(s) : Perez-Lloret S , Peralta MC , Barrantes FJ
Ref : Expert Opin Pharmacother , :1 , 2016
Abstract :
PubMedSearch : Perez-Lloret_2016_Expert.Opin.Pharmacother__1
PubMedID: 27785919

Title : Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease - Perez-Lloret_2016_NPJ.Parkinsons.Dis_2_16001
Author(s) : Perez-Lloret S , Barrantes FJ
Ref : NPJ Parkinsons Dis , 2 :16001 , 2016
Abstract :
PubMedSearch : Perez-Lloret_2016_NPJ.Parkinsons.Dis_2_16001
PubMedID: 28725692

Title : Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease - Perez-Lloret_2016_NPJ.Parkinsons.Dis_2_16001
Author(s) : Perez-Lloret S , Barrantes FJ
Ref : NPJ Parkinsons Dis , 2 :16001 , 2016
Abstract :
PubMedSearch : Perez-Lloret_2016_NPJ.Parkinsons.Dis_2_16001
PubMedID: 28725692

Title : Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration - Perez-Lloret_2016_Expert.Opin.Pharmacother__1
Author(s) : Perez-Lloret S , Peralta MC , Barrantes FJ
Ref : Expert Opin Pharmacother , :1 , 2016
Abstract :
PubMedSearch : Perez-Lloret_2016_Expert.Opin.Pharmacother__1
PubMedID: 27785919

Title : Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration - Perez-Lloret_2016_Expert.Opin.Pharmacother__1
Author(s) : Perez-Lloret S , Peralta MC , Barrantes FJ
Ref : Expert Opin Pharmacother , :1 , 2016
Abstract :
PubMedSearch : Perez-Lloret_2016_Expert.Opin.Pharmacother__1
PubMedID: 27785919

Title : Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease - Perez-Lloret_2016_NPJ.Parkinsons.Dis_2_16001
Author(s) : Perez-Lloret S , Barrantes FJ
Ref : NPJ Parkinsons Dis , 2 :16001 , 2016
Abstract :
PubMedSearch : Perez-Lloret_2016_NPJ.Parkinsons.Dis_2_16001
PubMedID: 28725692